The largest database of trusted experimental protocols

Leucovorin lv

Manufactured by Merck Group
Sourced in United States

Leucovorin (LV) is a form of the B vitamin folate. It is used in combination with certain chemotherapy medications to help reduce side effects and improve the effectiveness of the treatment.

Automatically generated - may contain errors

3 protocols using leucovorin lv

1

Evaluating Leucovorin's Cytotoxicity Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCT116 cells were allowed to grow in folic acid free DMEM for a few months until cells reached normal doubling time of about 20 h. Ten μmol/L of leucovorin (LV; Sigma, St. Louis, Missouri) was co-treated with 5-FU and F10 for 72 h as described before along with a drug control. Cell viability was assessed using Promega’s CellTiter-Glo assay as described before. Results were plotted using GraphPad Prism.
+ Open protocol
+ Expand
2

Evaluating Leucovorin's Cytotoxicity Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCT116 cells were allowed to grow in folic acid free DMEM for a few months until cells reached normal doubling time of about 20 h. Ten μmol/L of leucovorin (LV; Sigma, St. Louis, Missouri) was co-treated with 5-FU and F10 for 72 h as described before along with a drug control. Cell viability was assessed using Promega’s CellTiter-Glo assay as described before. Results were plotted using GraphPad Prism.
+ Open protocol
+ Expand
3

Synergistic Effects of FOLFOX Chemotherapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
L-OHP, 5-FU, and leucovorin (LV) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Stock solutions of these drugs were prepared in sterile distilled water with filtration. We chose concentrations of these drugs that caused 80%–90% growth reduction when used alone for HCT116 cell line: 2.5 µM of L-OHP, 25 µM of 5-FU, and 25 µM of LV. Cells were exposed to FL regimen (5-FU/LV) or folfox regimen (L-OHP/5-FU/LV) at 18 hours after transfection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!